Search

everythinglearnresearchcommunity

for

Search:↓

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Sorafenib can cause delayed skin problems, so patients need careful monitoring.

Cardiovascular drugs can cause various skin problems, so recognizing these reactions is important.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Intralesional corticosteroids and 5-alpha-reductase inhibitors are the best treatments for frontal fibrosing alopecia.

Brodalumab is more effective than ustekinumab for treating psoriasis.

PRIDE complex side effects from EGFR inhibitors can be managed without stopping treatment.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

Vemurafenib causes significant skin side effects, requiring regular dermatologist care and sun protection.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

Oral JAK inhibitors show promise for treating alopecia areata but have challenges like relapse and side effects.

Gefitinib can cause rare scarring hair loss.

5alpha-reductase inhibitors help treat hair loss and prostate issues but may cause sexual side effects.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Finasteride may cause sexual and psychological side effects by affecting an enzyme related to epinephrine.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

Three natural compounds from Ghanaian plants may help treat BPH and alopecia.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Valproic acid may cause hair loss by reducing biotinidase enzyme activity in rats.

Baricitinib can lead to hair regrowth in alopecia areata but may also cause relapses.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

Different people with severe hair loss respond to baricitinib treatment at different times, with some showing improvement early, some gradually, and others later.